Uvamin retard, Kapseln

7680359410298 CH-35941 Kapseln
Uvamin retard, Kapseln
Uvamin retard, Kapseln
Uvamin retard, Kapseln
1 / 3
google

Article details

Package size
30
Selling units
30
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
14/08/2025
Summary of Product Characteristics
Français
14/08/2025
Summary of Product Characteristics
Italien
14/08/2025
Patient information leaflet
Allemand
07/12/2023
Patient information leaflet
Français
07/12/2023
Patient information leaflet
Italien
07/12/2023

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
20.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 13.40
Specialties list
Yes
Generic
No
SL addition date: 01/11/2018

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
35941
Drug name
Uvamin retard, Kapseln
Galenic form
RETH
ATC Code
J01XE01
Authorization status
Z
Dispensing category
B
First authorization
15/03/1971
Authorization expiration date
31/12/9999
IT Number
08.01.9.
Domain
Human medicine
Field of application
Harnwegsinfektionen

Package details

Description (FR)
UVAMIN retard caps ret 100 mg 30 pce
Description (DE)
UVAMIN retard Ret Kaps 100 mg 30 Stk
Market launch
16/12/1996
Narcotic (BTM)
No